These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
498 related articles for article (PubMed ID: 33130103)
21. ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV. Lubbe L; Cozier GE; Oosthuizen D; Acharya KR; Sturrock ED Clin Sci (Lond); 2020 Nov; 134(21):2851-2871. PubMed ID: 33146371 [TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatory drugs and the renin-angiotensin-aldosterone system: Current knowledge and potential effects on early SARS-CoV-2 infection. Cabbab ILN; Manalo RVM Virus Res; 2021 Jan; 291():198190. PubMed ID: 33039544 [TBL] [Abstract][Full Text] [Related]
23. Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease. Potdar AA; Dube S; Naito T; Li K; Botwin G; Haritunians T; Li D; Casero D; Yang S; Bilsborough J; Perrigoue JG; Denson LA; Daly M; Targan SR; Fleshner P; Braun J; Kugathasan S; Stappenbeck TS; McGovern DPB Gastroenterology; 2021 Feb; 160(3):809-822.e7. PubMed ID: 33160965 [TBL] [Abstract][Full Text] [Related]
24. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2. Sharma RK; Stevens BR; Obukhov AG; Grant MB; Oudit GY; Li Q; Richards EM; Pepine CJ; Raizada MK Hypertension; 2020 Sep; 76(3):651-661. PubMed ID: 32783758 [TBL] [Abstract][Full Text] [Related]
25. Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa. Takabayashi T; Yoshida K; Imoto Y; Schleimer RP; Fujieda S Am J Rhinol Allergy; 2022 Jan; 36(1):115-122. PubMed ID: 34232770 [TBL] [Abstract][Full Text] [Related]
26. ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery. Lores E; Wysocki J; Batlle D Clin Sci (Lond); 2020 Nov; 134(21):2791-2805. PubMed ID: 33135725 [TBL] [Abstract][Full Text] [Related]
27. ACE2: from protection of liver disease to propagation of COVID-19. Warner FJ; Rajapaksha H; Shackel N; Herath CB Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956 [TBL] [Abstract][Full Text] [Related]
28. Interactions of renin-angiotensin system and COVID-19: the importance of daily rhythms in ACE2, ADAM17 and TMPRSS2 expression. Zlacká J; Stebelová K; Zeman M; Herichová I Physiol Res; 2021 Dec; 70(S2):S177-S194. PubMed ID: 34913351 [TBL] [Abstract][Full Text] [Related]
29. Withanone from Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804 [TBL] [Abstract][Full Text] [Related]
30. Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19. Lu L; Liu X; Jin R; Guan R; Lin R; Qu Z Biomed Res Int; 2020; 2020():7520746. PubMed ID: 33204713 [TBL] [Abstract][Full Text] [Related]
31. ACE/ACE2 balance might be instrumental to explain the certain comorbidities leading to severe COVID-19 cases. Bank S; De SK; Bankura B; Maiti S; Das M; A Khan G Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33442728 [TBL] [Abstract][Full Text] [Related]
32. Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids. O'Beirne SL; Salit J; Kaner RJ; Crystal RG; Strulovici-Barel Y Respir Res; 2021 Jul; 22(1):200. PubMed ID: 34233672 [TBL] [Abstract][Full Text] [Related]
33. Classical and alternative receptors for SARS-CoV-2 therapeutic strategy. Masre SF; Jufri NF; Ibrahim FW; Abdul Raub SH Rev Med Virol; 2021 Sep; 31(5):1-9. PubMed ID: 33368788 [TBL] [Abstract][Full Text] [Related]
34. ACE2 - from the renin-angiotensin system to gut microbiota and malnutrition. Perlot T; Penninger JM Microbes Infect; 2013 Nov; 15(13):866-73. PubMed ID: 23962453 [TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2, ACE2 expression, and systemic organ invasion. Ashraf UM; Abokor AA; Edwards JM; Waigi EW; Royfman RS; Hasan SA; Smedlund KB; Hardy AMG; Chakravarti R; Koch LG Physiol Genomics; 2021 Feb; 53(2):51-60. PubMed ID: 33275540 [TBL] [Abstract][Full Text] [Related]
36. Colonic expression of Edwinson A; Yang L; Chen J; Grover M Gut Microbes; 2021; 13(1):1984105. PubMed ID: 34632957 [TBL] [Abstract][Full Text] [Related]
37. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology. Vieira C; Nery L; Martins L; Jabour L; Dias R; Simões E Silva AC Curr Drug Targets; 2021; 22(3):254-281. PubMed ID: 33081670 [TBL] [Abstract][Full Text] [Related]
38. Receptor utilization of angiotensin-converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV. Wang Q; Qiu Y; Li JY; Liao CH; Zhou ZJ; Ge XY Transbound Emerg Dis; 2021 May; 68(3):1046-1053. PubMed ID: 32794346 [TBL] [Abstract][Full Text] [Related]
39. Functional Complexes of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Receptors: Expression in Adult but Not Fetal Lung Tissue. Franco R; Lillo A; Rivas-Santisteban R; Rodríguez-Pérez AI; Reyes-Resina I; Labandeira-García JL; Navarro G Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339432 [TBL] [Abstract][Full Text] [Related]
40. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19? Hu Y; Liu L; Lu X Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]